WCN26-6275 Single-Agent Treatment with an ALK5 Inhibitor or an SGLT2 Inhibitor (Dapagliflozin) Attenuates Renal Fibrosis in the UUO Mouse Model
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Fields of Study & Subjects
Publication details
- Journal / source
- Kidney International Reports
- Volume
- 11
- Issue
- 4
- Pages
- 105393–105393
- Publication date
- 25 March 2026
- Language
- EN